Adipose-derived mesenchymal stem cells and regenerative medicine

Dev Growth Differ. 2013 Apr;55(3):309-18. doi: 10.1111/dgd.12049. Epub 2013 Mar 3.

Abstract

Adipose tissue-derived mesenchymal stem cells (ADSCs) are multipotent and can differentiate into various cell types, including osteocytes, adipocytes, neural cells, vascular endothelial cells, cardiomyocytes, pancreatic β-cells, and hepatocytes. Compared with the extraction of other stem cells such as bone marrow-derived mesenchymal stem cells (BMSCs), that of ADSCs requires minimally invasive techniques. In the field of regenerative medicine, the use of autologous cells is preferable to embryonic stem cells or induced pluripotent stem cells. Therefore, ADSCs are a useful resource for drug screening and regenerative medicine. Here we present the methods and mechanisms underlying the induction of multilineage cells from ADSCs.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adipose Tissue / cytology*
  • Animals
  • Bone Marrow Cells / cytology
  • Humans
  • Mesenchymal Stem Cells / cytology*
  • Regenerative Medicine / methods*